William E Berger
Overview
Explore the profile of William E Berger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
528
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pongracic J, Gagnon R, Sussman G, Siri D, Oriel R, Brown-Whitehorn T, et al.
J Allergy Clin Immunol Pract
. 2025 Mar;
PMID: 40023371
Background: Due to limited treatment options for peanut allergy, patients remain at risk for allergic reactions due to accidental exposure. Epicutaneous immunotherapy (EPIT) is a novel treatment being investigated for...
2.
In perennial allergic rhinitis, RQLQ is improved similarly by Azelastine 0.15 and mometasone furoate
Bousquet J, Klimek L, Kuhl H, Nguyen D, Ramalingam R, Canonica G, et al.
World Allergy Organ J
. 2025 Jan;
18(1):101021.
PMID: 39885937
Clinical Trial Registry Number: NCT00720382.
3.
Berger W, Faris N, Weinstein M, Wilding G, Berglund E
Ann Allergy Asthma Immunol
. 2025 Jan;
PMID: 39842774
Background: Oral mucosal immunotherapy (OMIT) involves the use of a specifically formulated toothpaste to deliver allergenic proteins to immunologically active areas of the oral cavity. This represents a novel delivery...
4.
Bousquet J, Klimek L, Liu M, Nguyen D, Ramalingam R, Canonica G, et al.
Clin Pharmacol Drug Dev
. 2025 Jan;
14(3):217-222.
PMID: 39789734
The primary objective of the study was to determine the bioavailability of 2 new formulations of azelastine (AZE) hydrochloride (0.10% and 0.15% AZE) containing sorbitol and sucralose compared with the...
5.
Bousquet J, Klimek L, Kuhl H, Nguyen D, Ramalingam R, Canonica G, et al.
Int Arch Allergy Immunol
. 2024 Dec;
1-8.
PMID: 39647474
Introduction: Allergic rhinitis (AR) affects up to 40% of the pediatric population. The US practice parameter recommends the use of intranasal antihistamines (INAH) or INCS as first-line therapy for the...
6.
Conway A, Gupta E, Verdi M, Berger W, Anagnostou A, Abrams E, et al.
J Allergy Clin Immunol Pract
. 2024 Jul;
12(10):2678-2686.
PMID: 38996838
For clinicians involved in improving healthcare for patients with allergic and immunologic conditions, advocacy on a broader level through public outreach is key to advancing value-based care. In this article,...
7.
Bousquet J, Klimek L, Kuhl H, Nguyen D, Ramalingam R, Canonica G, et al.
Front Allergy
. 2023 Nov;
4:1244012.
PMID: 37920410
Background: Azelastine hydrochloride (AZE) is a selective, non-sedating H1 antagonist with anti-inflammatory and mast cell stabilizing properties, which can be used as an alternative to intranasal corticosteroids. The objective of...
8.
Pongracic J, Gagnon R, Sussman G, Siri D, Oriel R, Brown-Whitehorn T, et al.
J Allergy Clin Immunol Pract
. 2021 Dec;
10(7):1864-1873.e10.
PMID: 34848381
Background: Treatment options for peanut allergy are limited. In previous clinical trials, epicutaneous immunotherapy with a patch containing 250-μg peanut protein (Viaskin Peanut 250 μg [VP250]) was well tolerated and...
9.
Klimek L, Berger W, Bousquet J, Keith P, Smith P, Sole D, et al.
Int Arch Allergy Immunol
. 2021 Jun;
182(11):1026-1035.
PMID: 34082425
Allergic rhinitis (AR) is prevalent, and many patients present with moderate-to-severe symptomatic disease. The majority of patients are not satisfied with their AR treatment, despite the use of concurrent medications....
10.
Abella B, Berger W, Blaiss M, Stiell I, Herres J, Moellman J, et al.
Ann Emerg Med
. 2020 Jul;
76(4):489-500.
PMID: 32653333
Study Objective: Acute urticaria is a frequent presentation in emergency departments (EDs), urgent care centers, and other clinical arenas. Treatment options are limited if diphenhydramine is the only intravenous antihistamine...